コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 an adapter TNF receptor-associated factor 4 (TRAF4).
2 F5, and TRAF6, but not with TRAF2, TRAF3, or TRAF4.
3 which is associated with Rac1 activation by TRAF4.
4 f p47(phox) and the conserved TRAF domain of TRAF4.
5 sociate and binds to human TRAF1, TRAF2, and TRAF4.
6 t contribute to anti-HER2 resistance, making TRAF4 a viable target for treating HER2 + breast cancer.
9 KK4 binds the TRAF domain of TRAF4 and MEKK4/TRAF4 activation of JNK is inhibited by expression of th
12 and Axin each bind and activate MEKK4, with TRAF4 and Axin binding to the kinase domain and GADD45 b
13 we show that similar to the interaction with TRAF4 and Axin, the kinase domain of MEKK4 interacts wit
14 es in NOD2 are required for interaction with TRAF4 and inhibition of NOD2 signaling because mutation
15 pathways in the embryo; however, the role of TRAF4 and its association with MAP3K4 in the placenta is
19 activate JNK independently, coexpression of TRAF4 and MEKK4 results in synergistic activation of JNK
24 RAF4 in TS cells and highlight these MAP3K4, TRAF4, and HDAC6 associations during placental developme
25 , we examine the relationships among MAP3K4, TRAF4, and HDAC6 in the developing placenta, finding a p
32 s factor (TNF)-receptor-associated factor-4 (TRAF4) as a new target of Smurf1, which polyubiquitylate
33 ecrosis factor receptor-associated factor 4 (TRAF4) as a novel direct target of miR-29s and revealed
34 e identify TNF receptor associated factor 4 (TRAF4) as a novel Draper binding partner that is require
35 ctor-associated factor (TRAF) family member, TRAF4, as a key negative regulator of NOD2 signaling.
40 ecrosis factor receptor-associated factor 4 (TRAF4) binds MAP3K4 and promotes MAP3K4 activation of do
41 xpression of the p47(phox) binding domain of TRAF4 blocked endothelial cell JNK activation by TNFalph
42 mechanism, we showed that the TRAF domain of TRAF4 bound to the N-terminal TRAF-like region of the de
44 addition, a fusion between p47(phox) and the TRAF4 C terminus constitutively activated JNK, and this
46 icroenvironment and described a novel miR-29-TRAF4-CD40 signaling axis modulated by BCR activity.
51 MOG35-55 specific wild-type Th17 cells into TRAF4-deficient recipient mice induced an earlier onset
54 complex with TRAF4 in TS cells and promotes TRAF4 expression in the absence of HDAC6 deacetylase act
57 ing embryo, as well as in the adult, lack of TRAF4 expression results in a localized, developmental d
61 In contrast to its other family members, TRAF4 has not been shown to bind to a member of the tumo
66 udy reveal the necessity of a unique role of TRAF4 in restricting the effects of IL-17 signaling and
68 chanisms of MAP3K4 and HDAC6 coregulation of TRAF4 in TS cells and highlight these MAP3K4, TRAF4, and
69 ound that HDAC6 forms a protein complex with TRAF4 in TS cells and promotes TRAF4 expression in the a
71 on of olfactory receptor gene transcription, TRAF4 increases intracellular cAMP levels and boosts E2F
76 dary screen of endothelial cell proteins for TRAF4-interacting partners yielded a number of proteins
80 lacenta single-cell RNA-Seq data showed that Traf4 is coexpressed with Map3k4 in trophoblast stem (TS
86 ignaling during Trastuzumab treatment, while TRAF4 knockdown reduced HER2 stability and improved Tras
87 t target of miR-29s and revealed that higher TRAF4 levels increase CLL responsiveness to CD40 activat
88 interfering RNA knockdown of Smurf1 elevates TRAF4 levels, indicating endogenous regulation of TRAF4
91 correlation that the orphan adaptor protein TRAF4 may play a role in p53-mediated proapoptotic signa
99 rest development and neural folding, whereas TRAF4 overexpression boosts signaling and expands the ne
100 ast cancers and further found that SRC-3 and TRAF4 overexpression diminished cytotoxic stress-induced
101 h this cellular function, we also found that TRAF4 overexpression in breast cancer patients was assoc
103 usceptibility protein, NOD2, is required for TRAF4 phosphorylation and subsequent inhibition of NOD2
107 ough site-directed mutagenesis we found that TRAF4 promotes an atypical K29-linked ubiquitination at
112 HER2 signaling regulation that involves the TRAF4-SMURF2 complex, a possible mechanism that might co
115 ated it leading to HER2 degradation, whereas TRAF4 stabilized HER2 by degrading SMURF2 and inhibiting
117 resides within an exaggerated beta-bulge in TRAF4 that is not present in the other TRAF proteins, an
119 ation is required for proper localization of TRAF4 to tight junctions in confluent epithelial cells.
121 d TRAF family proteins (TRAF1, TRAF2, TRAF3, TRAF4, TRAF5, and TRAF6), whereas the TD of SPOP interac
123 roach, we identified a SRC-3 downstream gene-TRAF4 (tumor necrosis factor [TNF] receptor associated-f
124 expression via MYC, allowing for concurrent TRAF4 upregulation and stronger CD40-NF-kB signaling.
129 ssion of proapoptotic proteins caspase-9 and TRAF4 was seen in endothelial cells and smooth muscle ce
131 NF receptor-associated factor-2 (TRAF2), and TRAF4 were clearly inducible via CD40 in B cells but not
132 se adaptor p47(phox) and its binding partner TRAF4 were sequestered within nascent, focal complexlike
133 as the proapoptotic molecules caspase-3 and TRAF4, which are downregulated during development, and t
134 the coexpression of Traf4 with Map3k4 versus Traf4 with Hdac6 during differentiation of the placental
135 iously unknown switch in the coexpression of Traf4 with Map3k4 versus Traf4 with Hdac6 during differe